Research location
Clydebank
West Dunbartonshire, United Kingdom
Advertisement
Research activity in Clydebank
West Dunbartonshire, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Clydebank
9 linked trials · page 1 of 1Nailfold Capillaroscopy in PHNCT07768644 · 2026-05-20 · 1 site observation
RECRUITING
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapyNCT02891850 · 2017-01-11 · 1 site observation
COMPLETED
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHNCT02725372 · 2016-04-01 · 1 site observation
TERMINATED
Selonsertib in Adults With Pulmonary Arterial HypertensionNCT02234141 · 2014-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)NCT02138825 · 2014-06-04 · 1 site observation
TERMINATED
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 InhibitorNCT02007629 · 2014-02-18 · 1 site observation
COMPLETED
Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.NCT01179334 · 2010-08-01 · 1 site observation
COMPLETED
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial HypertensionNCT00863681 · 2009-03-12 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)NCT00810693 · 2008-12-17 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.